Needle-Free Injection Systems Market Size, Share, and Demand Analysis By Product (Fillable, Prefilled), Type (Liquid-Based, Projectile/Depot-Based, Powder-Based), Technology (Jet-Based, Spring-Based, Laser-Powered), Usability (Disposable, Reusable), Delivery Site (Subcutaneous, Intramuscular, Intradermal), Application (Vaccine Delivery, Insulin Delivery, Pain Management), End User (Hospitals & Clinics, Home-Care Settings, Research Laboratories) – Forecast to 2030

Market Overview

The global needle-free injection systems market was valued at $151.0 million in 2021, and it is projected to expand with a CAGR of 13.3% during 2021–2030, to generate $466.2 million by 2030. This can be ascribed to the worldwide growing diabetic population, which generates high demand for self-injection devices; increasing prevalence of needlestick injuries; and fear of needles among people.

Prefilled Needle-Free Injectors Expected to Witness Faster Growth

Prefilled needle-free injection devices are expected to grow with the faster CAGR, more than 14%, during 2021–2030. This is primarily because the majority of these prefilled syringes are automated, reducing the risk of physical handling and ensuring a safer use. Moreover, the U.S. is the largest revenue contributor to the prefilled needle-free injectors market, due to the large diabetic and chronic disease patient base in the country. Furthermore, these advanced systems help patients to reduce the risk of contamination or human-caused dosing errors. Due to the aforementioned factors, the demand for prefilled needle-free injectors is increasing across the world.

Liquid-Based Category Accounted Largest Market Share

In 2021, the liquid-based needle-free injection systems held around 70% share in the market. This can be ascribed to the technological advancements, and the easy usage of needle-free injection technology, which makes it more popular in the market.

Rising Number of Needlestick Injuries Propels the Market

The upsurge in needlestick injuries is projected to boost the demand for needle-free injectors. These injectors reduce the risk of needlestick injuries and help patients overcome needle fear. They also restrict the transmission of infectious diseases by avoiding cross-contamination. Needlestick injuries can cause contagious diseases such as HIV-AIDS, Hepatitis-B, and Hepatitis-C. To reduce the cases of contagious diseases, needle-free injection systems have gained popularity.

Explore more about this report - Request free sample

Jet-Based Technology Generates the Largest Revenue

The jet-based technology contributes the largest revenue to the needle-free injection systems market, and the category is projected to expand with a CAGR of around 14% during 2021–2030. This can be attributed to its benefits, including less time being spent on preparing and administering the medication, fewer needlestick injuries, convenience in usage and aesthetics, and a lower chance of disease spreading.

The laser-powered category is projected to exhibit healthy growth during the forecast period. This growth can be attributed to its ability to precisely manage drug delivery quantity and depth, and its high adoption rates in aesthetic skin treatment techniques.

Reusable Needle-Free Injectors Are Higher Revenue Contributor to the Market

Reusable needle-free injection devices are accounted for higher revenue in the market. This is primarily ascribed to the feature of refilling injectors for multiple uses. On the other hand, disposable needle-free injectors are expected to grow faster in the coming years. This is due to the disposable feature of these needles that avoid needlestick injuries and cross-contamination.

Increasing Demand for Self-Injection Systems Drives the Market

Patients with chronic conditions who use self-injection devices have more control over their treatment schedules, allowing them to become more independent and freer in their social, personal, and working activities. Self-injection may provide psychological advantages over professional administration, such as increased self-esteem. Eliminating the need for frequent injections at a clinic or hospital, ultimately keeps costs down for both the patients and medical systems. Thus, the cost-effectiveness of self-injection devices has been a primary driver of the needle-free injection systems market growth.

Insulin Delivery Is the Fastest-Growing Application Category

Needle-free injection systems are highly used for insulin delivery. This is ascribed to the huge diabetic population base that uses a large number of insulin delivery devices and the fear of needles or syringes among people. Furthermore, since there is no risk of needlestick injury, it is a viable option to be used at home and in healthcare settings. As a result, the demand for needle-free injectors for insulin delivery is increasing.

Subcutaneous Injectors Accounted for Largest Market Share

The subcutaneous injectors category accounted for the largest revenue share in the market in 2021, and it is expected to maintain its position during the forecast period as well. This is because when a medicine is administered, it moves into the capillaries and is delivered to the bloodstream from there.

Hospitals and clinics are the largest end user of needle-free injection devices and the category accounts for the highest market share. This is attributed to the technical advancements, rise in demand for vaccinations, and increase in usage of medication delivery systems due to the high-patient traffic in hospitals and clinics. Whereas, the fastest growth is observed in the home care settings category during the forecast period, due to the rapid upsurge in the number of diabetic patients.

North America Leads the Market

The North American needle-free injection systems market held the largest revenue share, of over 40%, in 2021, and it is expected to lead the market in the future as well. This is due to the presence of well-developed healthcare infrastructure, high level of patient awareness, increase in cases of chronic diseases, and high R&D spending on needle-free injection technologies.

On the other hand, the APAC market will register the fastest growth during the forecast period. This can be ascribed to the rise in disposable income and increase in public healthcare expenditure in developing economies of the region. Moreover, the surging adoption rate of needle-free injectors for vaccination of several medical conditions is another factor responsible for the regional market growth.

Strategic Developments Adopted by Key Players in the Market

Key players in the market have been engaged in partnerships and clinical trials to gain a competitive edge. For instance:

• In January 2022, PharmaJet Inc., Zydus Cadila, and Enzychem Lifesciences announced their partnership to manufacture their COVID-19 plasmid DNA vaccine (ZyCoV-D) in Korea.
• In October 2020, PharmaJet Inc.’s needleless vaccine injector was chosen by the University of Cambridge for the phase-1 trial of DIOSynVax's candidate, a COVID-19 vaccine. The trial would test the delivery of the vaccine without using needles through the skin.

Top Manufacturers of Needle-Free Injection Systems Are:

• Portal Instruments Inc.
• Inovio Pharmaceuticals Inc.
• National Medical Products Inc.
• PenJet Corporation
• PharmaJet Inc.

Market Size Breakdown by Segment

The report offers comprehensive market segmentation analysis along with the revenue estimation for the period 2017–2030.

Based on Product

• Fillable
• Prefilled

Based on Type

• Liquid-Based
• Projectile/Depot-Based
• Powder-Based

Based on Technology

• Jet-Based
• Spring-Based
• Laser-Powered

Based on Usability

• Disposable
• Reusable

Based on Delivery Site

• Subcutaneous
• Intramuscular
• Intradermal

Based on Application

• Vaccine Delivery
• Insulin Delivery
• Pain Management

Based on End User

• Hospitals & Clinics
• Home-Care Settings
• Research Laboratories

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • Saudi Arabia
  • South Africa